1. Back to Arbeitsgruppen

Monogenic Network

The Monogenic Network is comprised of the Sample Prioritization, Data Analysis, and Portal Development working groups, and studies patients and families with a mutation in a single gene causing Parkinson’s disease.

About the Monogenic Network

The Monogenic Network aims to identify novel genetic causes of apparently monogenic Parkinson’s disease (PD) – forms of PD where pathogenic variants in a single PD-linked gene are considered causative of the disease. The Monogenic Network is comprised of the groups Sample Prioritization, Data Analysis, and Portal Development.

Leveraging GP2’s global network of researchers contributing patient samples, the Monogenic Network will collect thousands of patients and relatives from families in whom a monogenic cause is suspected. Emphasis will be placed on families from underrepresented populations. All currently known PD genes have been found in various populations around the globe, however, some occur at highly variable and population-specific frequencies. The most striking example being the G2019S mutation in the LRRK2 gene. In addition, it is conceivable that population-specific hereditary forms of PD may exist, as exemplified by X-linked dystonia-parkinsonism, a condition exclusively present in patients of Filipino ancestry.

The Monogenic Network will collect families and single cases, as well as parent-offspring trios, through the Monogenic Portal. These will be prioritized by Sample Prioritization for whole-genome sequencing or long-read sequencing based on a number of different criteria, such as family history, availability of samples from several affected family members, age at onset and ethnicity. The Data Analysis group will analyze genome data for the presence of potentially novel pathogenic variants.

The Monogenic Network invites collaborators to participate in the Network's open meetings once a month.

Lernen Sie die Leads und Co-Leads kennen

Führen

Christine Klein, MD

University of Luebeck | Deutschland

Co-Leitung

Niccolò Emanuele Mencacci, MD, PhD

Northwestern University, Northwestern University | Chicago

Co-Leitung

Joanne Trinh, PhD

University of Lübeck | Lübeck

Lernen Sie die Teilnehmer kennen

Mitglied

Shen-Yang Lim

University of Malaya | Malaysia

Mitglied

Melina Ellis

Concord Hospital | Sydney

Mitglied

Lara Lange, MD

University of Lübeck and University Medical Center Schleswig-Holstein | Bethesda

Mitglied

Ignacio Juan Keller Sarmiento, MD

Northwestern University | USA

Mitglied

Harutyun Madoev

University of Luebeck | Deutschland

Mitglied

Ai Huey Tan, MD, PhD

University of Malaya | Kuala Lumpur

Mitglied

Enza Maria Valente, MD, PhD

University of Pavia, IRCCS Mondino Foundation | Mailand

Mitglied

Micol Avenali, MD, PhD

University of Pavia, Fondazione Istituto Neurologico Nazionale Casimiro Mondino | Pavia

Mitglied

Zih-Hua Fang, PhD

German Center for Neurodegenerative Diseases

Mitglied

Azlina Ahmad-Annuar

University of Malaya | Malaysia

Mitglied

Cholpon Shambetova, MD

Kyrgyz State Medical Academy, University of Luebeck | Bischkek

Mitglied

Kishore Kumar, PhD

Garvan Institute of Medical Research and Concord Repatriation General Hospital | Australien

Mitglied

Soraya Bardien, PhD

Stellenbosch University | Cape Town

Mitglied

Thomas Gasser, MD

University of Tübingen | Deutschland

Mitglied

Peter Heutink, PhD

unknown | Montieri

Mitglied

Alexander Balck, MD

University of Lübeck | Deutschland

Mitglied

Paola Dimartino, PhD

University of Pavia | Pavia

Mitglied

Caterina Galandra, PhD

IRCCS Mondino Foundation | Italien

Mitglied

Carolin Gabbert, PhD

the University of Lübeck | Lübeck

Mitglied

Laura Rudaks, MBBS

University of Sydney, Concord Repatriation General Hospital, Garvan Institute of Medical Research | Sydney

Mitglied

Dennis Yeow, BSc,MBBS

NeuRA, Garvan Institute of Medical Research | Sydney

Mitglied

Christoph Westenberger, MSc

University of Lübeck | Lübeck

Mitglied

Anne-Marie Wills, MD

Harvard Medical School | Boston

Mitglied

Roberta Torricelli, BSc

Queen Mary University | London

Mitglied

Teresa Kleinz, MD

Institute of Neurogenetics, Lübeck | Lübeck

Meilensteine

Active

  • Monogenic Network website and Monogenic Portal developed and online
  • Collected ~4,000 samples eligible for inclusion into the Monogenic Network
  • Recruited over 70 centers to participate
  • Developed and established genetic analysis pipeline
  • Welcomed over 15 visitors and trainees at different research institutions of members of the Monogenic Network
  • Established the Return of results working group within the Monogenic Network

Es wurden ca. 4.000 Proben gesammelt, die in das monogene Netzwerk aufgenommen werden können.

    Aktiv